Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 2Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 5Neoplasms 5Multiple Myeloma 5Depression 5Sleep Initiation and Maintenance Disorders 4Ovarian Neoplasms 4Lung Neoplasms 4Fatigue 4Breast Carcinoma In Situ 4Motor Activity 3Leukemia 3Uterine Cervical Neoplasms 2Sleep Wake Disorders 2Pancreatic Neoplasms 2Pain 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid 2Leukemia, Lymphoid 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Anxiety Disorders 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Torulopsis 1

Interventions

Cisplatin 72Brachytherapy 31Radiotherapy 26Paclitaxel 23Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21human papillomavirus vaccine, L1 type 16, 18 20Topotecan 18Papillomavirus Vaccines 18Carboplatin 18Surveys and Questionnaires 17Bevacizumab 16pembrolizumab 14Radiation 12Gemcitabine 12Early Intervention, Educational 12Colposcopy 12Methods 11Magnetic Resonance Spectroscopy 11atezolizumab 10Radiotherapy, Intensity-Modulated 10Blood Specimen Collection 10Papanicolaou Test 9Docetaxel 9Vaccines, Synthetic 8Platinum 8Nivolumab 8Ipilimumab 8Counseling 81,2-diaminocyclohexaneplatinum II citrate 8Vaccines 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Neoplasms × Behavior Therapy × Clear all
NCT05025748 2023-08-16

Ask Questions (ASQ):Implementation of a Communication Intervention

Barbara Ann Karmanos Cancer Institute

Phase NA Completed
81 enrolled
BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT01764789 2015-10-09

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
39 enrolled
BreastGynecologic

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Fatigue, Leydig Cell Tumor, Pain, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡